Raymond James Financial’s BlackRock Health Sciences Trust BME Stock Holding History

Raymond James Financial’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.14M	Buy	107,436 +1,769	+2%	+$72.9K	﹤0.01%	2743
2025 Q4	$4.35M	Buy	105,667 +1,463	+1%	+$57.8K	﹤0.01%	2629
2025 Q3	$3.88M	Buy	104,204 +7,069	+7%	+$257K	﹤0.01%	2644
2025 Q2	$3.54M	Buy	97,135 +8,023	+9%	+$291K	﹤0.01%	2622
2025 Q1	$3.44M	Buy	89,112 +3,428	+4%	+$136K	﹤0.01%	2591
2024 Q4	$3.25M	Buy	+85,684	New	+$3.42M	﹤0.01%	2612

Other funds holding BME

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial's BME Position: Q1 2026 in Review

Raymond James Financial increased its BlackRock Health Sciences Trust (BME) stake by 1.7% in Q1 2026, buying an estimated $72.9K and bringing the position to 107,436 shares worth $4.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2743.

Raymond James Financial first reported a position in BME in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.35M in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

Raymond James Financial held 107,436 shares of BlackRock Health Sciences Trust worth $4.14M as of Q1 2026.
Raymond James Financial bought 1,769 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $72.9K.
BlackRock Health Sciences Trust made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2743 holding.
Raymond James Financial first reported a position in BlackRock Health Sciences Trust in Q4 2024 and has held it in 6 quarters since.
Raymond James Financial's BlackRock Health Sciences Trust position peaked at $4.35M in Q4 2025.
76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.